BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6108995)

  • 1. Degradation of melanotropin inhibiting factor by brain.
    Hui KS; Cheng KP; Wong KH; Salschutz M; Lajtha A
    J Neurochem; 1980 Aug; 35(2):471-8. PubMed ID: 6108995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of prolylleucylglycinamide (MIF) by mouse brain.
    Neidle A; Yessaian N; Lajtha A
    Neurochem Res; 1980 Sep; 5(9):1011-23. PubMed ID: 6111031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain.
    Zadina JE; Kastin AJ; Krieg EF; Coy DH
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1193-8. PubMed ID: 6131435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
    Bausback HH; Ward PE
    Biochim Biophys Acta; 1986 Jul; 882(3):437-44. PubMed ID: 2873842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-proline dipeptidyl-aminopeptidase from synaptosomal membranes of guinea-pig brain. A possible role for this activity in the hydrolysis of His-ProNH2, arising from the action of synaptosomal membrane pyroglutamate aminopeptidase on thyroliberin.
    O'Connor B; O'Cuinn G
    Eur J Biochem; 1986 Jan; 154(2):329-35. PubMed ID: 2867901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major localization of aminopeptidase M in rat brain microvessels.
    Solhonne B; Gros C; Pollard H; Schwartz JC
    Neuroscience; 1987 Jul; 22(1):225-32. PubMed ID: 2888044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of L-prolyl-L-leucylglycinamide (MIF-1) for the high-performance liquid chromatographic determination of proline iminopeptidase activity in rat liver.
    Hiraoka BY; Harada M
    J Chromatogr; 1991 Jan; 563(1):142-6. PubMed ID: 1676401
    [No Abstract]   [Full Text] [Related]  

  • 8. Degradation of oxytocin by the human placenta: effect of selective inhibitors.
    Mizutani S; Yokosawa H; Tomoda Y
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):76-80. PubMed ID: 1355623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional differences in the metabolism of Tyr-MIF-1 and Tyr-W-MIF-1 by rat brain mitochondria.
    Kastin AJ; Hahn K; Banks WA; Zadina JE
    Biochem Pharmacol; 1998 Jan; 55(1):33-6. PubMed ID: 9413927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of alkylaminonaphthylenesulfonyl peptides and amin acids by high-performance liquid chromatography. Methods for measuring melanotropin inhibiting factor breakdown.
    Hui KS; Salschutz M; Davis BA; Lajtha A
    J Chromatogr; 1980 May; 192(2):341-50. PubMed ID: 6104674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble and membrane-bound leucyl- and arginyl-aminopeptidase activities in subcellular fractions of young and adult rat brains.
    Ramírez M; Arechaga G; García S; Sánchez B; Lardelli P; Gandarias JM
    Rev Esp Fisiol; 1990 Dec; 46(4):393-7. PubMed ID: 2099537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminopeptidase activity in human nasal mucosa.
    Ohkubo K; Baraniuk JN; Hohman R; Merida M; Hersh LB; Kaliner MA
    J Allergy Clin Immunol; 1998 Nov; 102(5):741-50. PubMed ID: 9819290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl aminopeptidase from rat brain and kidney. Action on peptides and identification as leucyl aminopeptidase.
    Turzynski A; Mentlein R
    Eur J Biochem; 1990 Jul; 190(3):509-15. PubMed ID: 2373079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vaginal aminopeptidase enzymatic activities in various animals and in humans.
    Acartürk F; Parlatan ZI; Saracoğlu OF
    J Pharm Pharmacol; 2001 Nov; 53(11):1499-504. PubMed ID: 11732752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.
    Browne P; O'Cuinn G
    Eur J Biochem; 1983 Dec; 137(1-2):75-87. PubMed ID: 6140164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the melanotropin-inhibiting factor analogue pareptide in urine by high-performance liquid chromatography.
    Hui KS; Hui M; Cheng KP; Lajtha A; Boksay I; Fencik MU
    J Chromatogr; 1981 Mar; 222(3):512-7. PubMed ID: 6112231
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for conversion of N-Tyr-MIF-1 into MIF-1 by a specific brain aminopeptidase.
    Marks N; Berg MJ; Kastin AJ; Coy DH
    Neurochem Int; 1984; 6(3):347-53. PubMed ID: 20488055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring.
    Kheterpal I; Kastin AJ; Mollah S; Yu C; Hsuchou H; Pan W
    Peptides; 2009 Jul; 30(7):1276-81. PubMed ID: 19540426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
    Giros B; Gros C; Solhonne B; Schwartz JC
    Mol Pharmacol; 1986 Mar; 29(3):281-7. PubMed ID: 2869404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ontogeny of puromycin-sensitive and insensitive aminopeptidase activities in several subcellular fractions of the rat brain.
    de Gandarias JM; Irazusta J; Gil J; Fernández D; Varona A; Casis L
    Brain Res Bull; 1999 Nov; 50(4):283-90. PubMed ID: 10582526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.